Institutional Ownership Bio Line Rx Ltd. (BLRX)
This table provides information about the institutional ownership of Bio Line Rx Ltd. (BLRX). We have compiled data on the 36 institutions that hold shares in the stock, with a total of 2.83 Million shares, which have been reported (via 13F filing form) to have a value of $8.92 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
9,196
shares
|
$28,967
0.0% of portfolio
|
Q4 2024
Added 834.55%
|
|
|
Urban Wealth Management, LLC
|
Jul 22, 2022 Q2 2022 |
9,144
shares
|
$28,803
0.04% of portfolio
|
Q2 2022
New holding
|
|
|
Wells Fargo & Company
San Francisco, CA |
Feb 12, 2025 Q4 2024 |
5,535
shares
|
$17,435
0.0% of portfolio
|
Q4 2024
Reduced 84.2%
|
|
|
Geneos Wealth Management Inc.
|
Jan 21, 2025 Q4 2024 |
4,800
shares
|
$15,120
0.0% of portfolio
|
Q4 2024
Added 6.67%
|
|
|
New Edge Advisors, LLC
New Orleans, LA |
Feb 13, 2025 Q4 2024 |
4,300
shares
|
$13,545
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Feb 05, 2025 Q4 2024 |
3,104
shares
|
$9,777
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Feb 07, 2025 Q4 2024 |
1,206
shares
|
$3,798
0.0% of portfolio
|
Q3 2024
Reduced 14.22%
|
|
|
Tradewinds Capital Management, LLC
|
Feb 03, 2025 Q4 2024 |
200
shares
|
$630
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|